China Expects To Eliminate 60% Of Sterile Drugmakers Before 2014 GMP Deadline
This article was originally published in PharmAsia News
Executive Summary
China expects to eliminate 60% of sterile drug manufacturers before the year-end GMP certification deadline and has defined the focus areas of national social security.